Carmell Therapeutics Corporation (CTCX)
NASDAQ: CTCX · IEX Real-Time Price · USD
1.170
+0.080 (7.34%)
Jul 22, 2024, 10:37 AM EDT - Market open
Carmell Therapeutics Employees
As of December 31, 2023, Carmell Therapeutics had 10 total employees, including 9 full-time and 1 part-time employees. The number of employees decreased by 6 or -37.50% compared to the previous year.
Employees
10
Change (1Y)
-6
Growth (1Y)
-37.50%
Revenue / Employee
$2,192,022
Profits / Employee
-$767,327
Market Cap
23.24M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 10 | -6 | -37.50% |
Dec 31, 2022 | 16 | - | - |
Related Stocks
Company Name | Employees |
---|---|
ATA Creativity Global | 581 |
Local Bounti | 301 |
Four Seasons Education | 190 |
Maison Solutions | 174 |
Clene | 85 |
Top Wealth Group Holding | 12 |
CTCX News
- 3 months ago - Carmell Announces Successful Closing of $3.0 Million Private Placement - GlobeNewsWire
- 3 months ago - Carmell Announces $3.0 Million Private Placement - GlobeNewsWire
- 4 months ago - Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction - GlobeNewsWire
- 4 months ago - Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary - GlobeNewsWire
- 4 months ago - Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field - GlobeNewsWire
- 5 months ago - Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024 - GlobeNewsWire
- 8 months ago - Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors - GlobeNewsWire
- 11 months ago - Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine - PRNewsWire